Filing Details
- Accession Number:
- 0001179110-10-004231
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2010-03-02 12:00:00
- Reporting Period:
- 2010-02-26
- Filing Date:
- 2010-03-02
- Accepted Time:
- 2010-03-02 18:49:43
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1800 | Abbott Laboratories | ABT | Pharmaceutical Preparations (2834) | 360698440 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1298968 | C John Landgraf | 100 Abbott Park Road Abbott Park IL 60064-6400 | Senior Vice President | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Shares Without Par Value | Disposition | 2010-02-26 | 8,851 | $54.12 | 99,558 | No | 4 | F | Direct | |
| Common Shares Without Par Value | Disposition | 2010-02-26 | 11,283 | $54.42 | 88,275 | No | 4 | S | Direct | |
| Common Shares Without Par Value | Disposition | 2010-02-26 | 100 | $54.42 | 88,175 | No | 4 | S | Direct | |
| Common Shares Without Par Value | Disposition | 2010-02-26 | 600 | $54.42 | 87,575 | No | 4 | S | Direct | |
| Common Shares Without Par Value | Disposition | 2010-02-26 | 100 | $54.42 | 87,475 | No | 4 | S | Direct | |
| Common Shares Without Par Value | Disposition | 2010-02-26 | 500 | $54.42 | 86,975 | No | 4 | S | Direct | |
| Common Shares Without Par Value | Disposition | 2010-02-26 | 600 | $54.43 | 86,375 | No | 4 | S | Direct | |
| Common Shares Without Par Value | Disposition | 2010-02-26 | 200 | $54.43 | 86,175 | No | 4 | S | Direct | |
| Common Shares Without Par Value | Disposition | 2010-02-26 | 200 | $54.43 | 85,975 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | F | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Shares Without Par Value | 16,522 | Indirect | Profit Sharing Trust |
| Common Shares Without Par Value | 30,000 | Indirect | Anne Marie Landgraf Living Trust |
| Common Shares Without Par Value | 1,603 | Indirect | By self for son |
Footnotes
- Balance in the Abbott Laboratories Stock Retirement Trust as of February 25, 2010.
- Held in the Anne Marie Landgraf Living Trust. The reporting person and his spouse are co-trustees of the trust. The trust is revocable by his spouse.
- Includes shares acquired under the Abbott Laboratories Dividend Re-investment and Stock Purchase Plan in transactions exempt from Section 16 under Rule 16(a)-11.
- Reporting person disclaims beneficial ownership of all securities held by his son.
Billionaire Hedge Funds
